Thus, stabilization of TMBIM6 expression, inhibition of PS2 activation and preservation of mitochondrial function are promising therapeutic strategies to reduce reperfusion-caused cardiomyocyte dysfunction and heart failure. This evidence concerns the gene TMBIM6 and heart failure.